Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Atkin

Showing results (11-20 of 378) with videos related to

Pageof 38
Sort By:
Drug, Healthcare and Patient Safety|May 10, 2014
Patient safety and minimizing risk with insulin administration - role of insulin degludecMyint M Aye, Stephen L Atkin
Journal of Cellular Physiology|February 17, 2019
Use of stem cells as carriers of oncolytic viruses for cancer treatmentElham Zendedel, Stephen L Atkin, Amirhossein Sahebkar
Therapeutic Advances in Endocrinology and Metabolism|February 26, 2019
Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndromeHuda Alalami, Thozhukat Sathyapalan, Stephen L Atkin
Clinical Endocrinology|April 28, 2011
Pituitary hypophysitis and gulf war syndrome: a case series and hypothesisAmmar Wakil, Thozhukat Sathyapalan, Stephen L Atkin
Nutrition Research Reviews|December 5, 2014
How to measure mood in nutrition researchRichard Hammersley, Marie Reid, Stephen L Atkin
Journal of Obesity|January 4, 2011
Pharmacological treatment of obesity in patients with polycystic ovary syndromeHassan Kahal, Stephen L Atkin, Thozhukat Sathyapalan
Journal of Cellular Biochemistry|February 19, 2019
Natural compounds with DPP-4 inhibitory effects: Implications for the treatment of diabetesHabib Yaribeygi, Stephen L Atkin, Amirhossein Sahebkar
Journal of Cellular Physiology|February 27, 2019
Wingless-type inducible signaling pathway protein-1 (WISP1) adipokine and glucose homeostasisHabib Yaribeygi, Stephen L Atkin, Amirhossein Sahebkar
Journal of Cellular Biochemistry|August 31, 2018
Potential roles of microRNAs in redox state: An updateHabib Yaribeygi, Stephen L Atkin, Amirhossein Sahebkar
Diabetes & Metabolic Syndrome|July 25, 2019
Mechanistic effects of SGLT2 inhibition on blood pressure in diabetesHabib Yaribeygi, Stephen L Atkin, Amirhossein Sahebkar
Pageof 38

Showing results (11-20 of 378) with videos related to

Sort By:
Pageof 38
Drug, Healthcare and Patient Safety|May 10, 2014
Patient safety and minimizing risk with insulin administration - role of insulin degludecMyint M Aye, Stephen L Atkin
Journal of Cellular Physiology|February 17, 2019
Use of stem cells as carriers of oncolytic viruses for cancer treatmentElham Zendedel, Stephen L Atkin, Amirhossein Sahebkar
Therapeutic Advances in Endocrinology and Metabolism|February 26, 2019
Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndromeHuda Alalami, Thozhukat Sathyapalan, Stephen L Atkin
Clinical Endocrinology|April 28, 2011
Pituitary hypophysitis and gulf war syndrome: a case series and hypothesisAmmar Wakil, Thozhukat Sathyapalan, Stephen L Atkin
Nutrition Research Reviews|December 5, 2014
How to measure mood in nutrition researchRichard Hammersley, Marie Reid, Stephen L Atkin
Journal of Obesity|January 4, 2011
Pharmacological treatment of obesity in patients with polycystic ovary syndromeHassan Kahal, Stephen L Atkin, Thozhukat Sathyapalan
Journal of Cellular Biochemistry|February 19, 2019
Natural compounds with DPP-4 inhibitory effects: Implications for the treatment of diabetesHabib Yaribeygi, Stephen L Atkin, Amirhossein Sahebkar
Journal of Cellular Physiology|February 27, 2019
Wingless-type inducible signaling pathway protein-1 (WISP1) adipokine and glucose homeostasisHabib Yaribeygi, Stephen L Atkin, Amirhossein Sahebkar
Journal of Cellular Biochemistry|August 31, 2018
Potential roles of microRNAs in redox state: An updateHabib Yaribeygi, Stephen L Atkin, Amirhossein Sahebkar
Diabetes & Metabolic Syndrome|July 25, 2019
Mechanistic effects of SGLT2 inhibition on blood pressure in diabetesHabib Yaribeygi, Stephen L Atkin, Amirhossein Sahebkar
Pageof 38